Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Shares Issued: 2015-2024

Historic Shares Issued for Viking Therapeutics (VKTX) over the last 8 years, with Dec 2024 value amounting to $10.8 million.

  • Viking Therapeutics' Shares Issued fell 82.65% to $436,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 76.60%. This contributed to the annual value of $10.8 million for FY2024, which is 59.77% up from last year.
  • As of FY2024, Viking Therapeutics' Shares Issued stood at $10.8 million, which was up 59.77% from $6.8 million recorded in FY2023.
  • Over the past 5 years, Viking Therapeutics' Shares Issued peaked at $10.8 million during FY2024, and registered a low of $848,000 during FY2022.
  • Moreover, its 3-year median value for Shares Issued was $6.8 million (2023), whereas its average is $6.1 million.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 88.89% in 2022, then soared by 698.11% in 2023.
  • Over the past 4 years, Viking Therapeutics' Shares Issued (Yearly) stood at $7.6 million in 2021, then plummeted by 88.89% to $848,000 in 2022, then surged by 698.11% to $6.8 million in 2023, then spiked by 59.77% to $10.8 million in 2024.